Reducing Medication Errors in High-Performing Healthcare Orgs
This paper examines the organizational functions, processes, and behaviors that characterize high-performing healthcare organizations, with a specific focus on reducing medication errors. It reviews how technology such as machine learning, AI, IoT, and blockchain can improve medication safety, and how nursing education, communication, and interprofessional trust contribute to better outcomes. The paper applies the Plan-Do-Study-Act (PDSA) model as a framework for implementing change and outlines strategies for meaningful stakeholder engagement. It also presents arguments for securing organizational buy-in—including improved patient safety, cost reduction, enhanced patient satisfaction, and regulatory compliance—and offers concrete recommendations for sustaining long-term improvement in medication administration.
- Characteristics of High-Performing Healthcare Organizations: Shared traits of top-performing healthcare organizations
- Impact on Outcome Measures and the Performance Gap: How organizational behavior affects medication error outcomes
- Performance Issues and Opportunities for Improvement: Training gaps and communication failures driving errors
- PDSA Strategy for Measuring Patient Care and Sharing Knowledge: Applying the PDSA cycle to reduce medication errors
- Stakeholder Engagement: Identifying and involving key stakeholders in change
- Effective Arguments for Obtaining Agreement and Support: Safety, cost, and compliance arguments for organizational buy-in
- Recommendations for Implementing Change: Five actionable steps for sustainable improvement
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Connects abstract organizational theory directly to a concrete clinical problem—medication errors—keeping the argument grounded and practical throughout.
- Uses a recognized quality-improvement framework (PDSA) as the structural backbone, giving the recommendations both academic credibility and real-world applicability.
- Addresses multiple stakeholder groups explicitly, acknowledging that successful change requires buy-in from nurses, administrators, patients, and technology vendors alike.
Key academic technique demonstrated
The paper demonstrates evidence-based argumentation by pairing each proposed intervention (e.g., AI-assisted prescribing, enhanced nursing education) with a supporting citation from peer-reviewed or credible sources. This technique signals academic rigor while keeping claims defensible and grounded in the existing literature.
Structure breakdown
The paper opens by defining high-performing healthcare organizations, then narrows its focus to the specific performance gap around medication errors. It moves through a logical sequence: identifying the problem, applying the PDSA framework, outlining stakeholder engagement steps, constructing persuasive arguments for change, and closing with actionable implementation recommendations. The conclusion synthesizes the importance of sustained stakeholder collaboration, tying the earlier sections together into a unified call for continuous improvement.
Characteristics of High-Performing Healthcare Organizations
High-performing healthcare organizations exhibit several shared characteristics. They prioritize patient safety and quality of care through effective communication, teamwork, and a commitment to continuous learning and improvement (Rabkin & Frein, 2021). They also use technology to reduce medication errors — for example, leveraging IoT and blockchain for health monitoring (Alam et al., 2022). Others place strong emphasis on establishing trust among workers (Sifaki-Pistolla et al., 2020). These organizations also devote considerable attention to education and training, particularly in the areas of medication administration and medication reconciliation.
Impact on Outcome Measures and the Performance Gap
Organizational functions, processes, and behaviors significantly impact outcome measures associated with medication errors. Information systems can reduce medication errors by ensuring accurate administration; machine learning and AI systems are increasingly being used for that purpose (Corny et al., 2020). Adequate education and training enhance nursing competency, which can further decrease medication errors and adverse drug events. Effective communication and collaboration among healthcare providers also play a vital role in preventing errors and ensuring patient safety.
The performance gap related to medication errors can be addressed by focusing on specific outcomes and associated measures, such as reducing medication error rates and adverse drug events, improving medication reconciliation accuracy through technology, enhancing nursing competency in medication administration by building trust, and promoting communication and collaboration among healthcare providers.
Performance Issues and Opportunities for Improvement
Performance issues related to medication errors may be associated with a lack of adequate training for nurses, inefficient medication administration systems, and poor communication among healthcare providers. Conversely, opportunities for improvement include implementing more effective medication administration systems, enhancing nursing education and training, and fostering a culture of open communication and collaboration.
Conclusion
The journey to improving medication safety is a continuous process that requires full engagement and collaboration from all stakeholders in the healthcare organization. The payoff is a safer, more effective healthcare system that meets patients' needs and upholds the highest standards of care. Stakeholder buy-in is critical for the successful implementation and sustainability of changes aimed at reducing medication errors in a hospital setting. It is important to understand that stakeholder buy-in is not simply about agreeing to a proposed change — it is about understanding the reasons for the change, committing to its implementation, and taking ownership of its success.
To achieve this, hospitals must engage stakeholders early and often. Involving them in the planning stages ensures that their perspectives are considered and their concerns addressed. Stakeholders can include healthcare providers such as doctors and nurses, hospital administrators, patients, and external entities such as insurance companies or regulatory bodies. When all parties share a common understanding of the problem and a commitment to the solution, the organization is far better positioned to achieve lasting improvements in medication safety.
References
Alam, M. I., Haider, A. S., Siddiqui, A., Khan, M. R., Siddiqui, S. T., & Khan, H. (2022). IoT edge computing and blockchain for high-performance and decentralized health monitoring system. Available at SSRN 4157232.
Corny, J., Rajkumar, A., Martin, O., Dode, X., Lajonchère, J. P., Billuart, O., ... & Buronfosse, A. (2020). A machine learning–based clinical decision support system to identify prescriptions with a high risk of medication error. Journal of the American Medical Informatics Association, 27(11), 1688–1694.
Kaharuddin, S. K., Adnan, H., & Baharuddin, H. E. A. (2020). Success factors for stakeholder management for public-private partnerships infrastructure projects. Built Environment Journal (BEJ), 17(2), 1–10.
Rabkin, S. W., & Frein, M. (2021, August). Overcoming obstacles to develop high-performance teams involving physicians in health care organizations. In Healthcare (Vol. 9, No. 9, p. 1136). MDPI.
Reed, J., Barlow, J., Carmenta, R., van Vianen, J., & Sunderland, T. (2019). Engaging multiple stakeholders to reconcile climate, conservation and development objectives in tropical landscapes. Biological Conservation, 238, 108229.
Sifaki-Pistolla, D., Melidoniotis, E., Dey, N., & Chatzea, V. E. (2020). How trust affects performance of interprofessional health-care teams. Journal of Interprofessional Care, 34(2), 218–224.
Always verify citation format against your institution’s current style guide requirements.